<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fona Qorina</style></author><author><style face="normal" font="default" size="100%">Ade Arsianti</style></author><author><style face="normal" font="default" size="100%">Qotrunnada Fithrotunnisa</style></author><author><style face="normal" font="default" size="100%">NadzilaAnindya Tejaputri</style></author><author><style face="normal" font="default" size="100%">Norma Nur Azizah</style></author><author><style face="normal" font="default" size="100%">Rista Putrianingsih</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cytotoxicity of Soursop Leaves (Annona muricata) against Cervical HeLa Cancer Cells</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Annona muricata</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">HeLa cells</style></keyword><keyword><style  face="normal" font="default" size="100%">Soursop</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February  2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">20-24</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cervical cancer is the cancer with highest prevalence and the leading cause of women death in Indonesia. Current treatments available for cervical cancer are chemotherapy, radiation, surgery, and nuclear therapy. Unfortunately, these treatments still have several limitations due to serious side effects, development of resistance, and very expensive price. Therefore, it is necessary to develop effective and low-cost therapy to treat cervical cancer. One of which is by utilizing natural sources available in Indonesia such as soursop (&lt;em&gt;Annona muricata&lt;/em&gt;) leaves which has been used in folk medicine as a treatment for various diseases, including cancer. However, studies about its cytotoxicity against cervical cancer in Indonesia are still limited. &lt;strong&gt;Objective: &lt;/strong&gt;The aim of this research is to analyze the potency of &lt;em&gt;A.muricataleaves&lt;/em&gt; extracts originated from Indonesia as a novel alternative treatment for cervical cancer. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;&lt;em&gt;A.muricata&lt;/em&gt; leaves obtained from Serpong, West Java, Indonesia were grounded and macerated in three different solvents with various polarity, namely ethanol (polar solvent), ethyl acetate (semipolar solvent) and hexane (non-polar solvent). Subsequently, the extracts were diluted into 8 various concentrations. Cytotoxicity of &lt;em&gt;A.muricataleaves &lt;/em&gt;extracts against HeLa cervical cancer cells were determined by MTT assay and expressed by IC&lt;sub&gt;50 &lt;/sub&gt;value.&lt;strong&gt; Results: &lt;/strong&gt;The results showed that three extracts of &lt;em&gt;A.muricata&lt;/em&gt; have strong cytotoxicity against cervical HeLa cells. The highest cytotoxic activity was shown by etanol extract with an IC&lt;sub&gt;50&lt;/sub&gt; of 35.51 μg/mL, followed by ethyl acetate (IC&lt;sub&gt;50&lt;/sub&gt;: 5.91 μg/mL), and hexane (IC&lt;sub&gt;50&lt;/sub&gt;: 8.39 μg/mL). &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;A.muricata &lt;/em&gt;leaves extracts are potential to be developed as a novel alternative therapy for cervical cancer.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">20</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Fona Qorina&lt;sup&gt;1&lt;/sup&gt;, Ade Arsianti&lt;sup&gt;2,3,&lt;/sup&gt;*, Qotrunnada Fithrotunnisa&lt;sup&gt;1&lt;/sup&gt;, NadzilaAnindya Tejaputri&lt;sup&gt;1&lt;/sup&gt;, Norma Nur Azizah&lt;sup&gt;3&lt;/sup&gt;, Rista Putrianingsih&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Medical Student, Faculty of Medicine University of Indonesia, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Medical Chemistry, Faculty of Medicine, University of Indonesia, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Drug Development Research Cluster, Drug Discovery Division, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, University of Indonesia, Jalan Salemba Raya 6 Jakarta 10430, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>